Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen
about
Chlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidatesThe Waddlia genome: a window into chlamydial biologyA novel co-infection model with Toxoplasma and Chlamydia trachomatis highlights the importance of host cell manipulation for nutrient scavengingExpression, processing, and localization of PmpD of Chlamydia trachomatis Serovar L2 during the chlamydial developmental cycleComparative expression profiling of the Chlamydia trachomatis pmp gene family for clinical and reference strainsAnalysis of pmpD expression and PmpD post-translational processing during the life cycle of Chlamydia trachomatis serovars A, D, and L2Chlamydial protease-like activity factor--insights into immunity and vaccine developmentChlamydia spp. development is differentially altered by treatment with the LpxC inhibitor LPC-011.Adaptive evolution of the Chlamydia trachomatis dominant antigen reveals distinct evolutionary scenarios for B- and T-cell epitopes: worldwide survey.Membrane vesicle production by Chlamydia trachomatis as an adaptive responseRectal administration of a chlamydial subunit vaccine protects against genital infection and upper reproductive tract pathology in mice.Genome sequencing of recent clinical Chlamydia trachomatis strains identifies loci associated with tissue tropism and regions of apparent recombinationChlamydia trachomatis polymorphic membrane protein D is a virulence factor involved in early host-cell interactions.Chlamydia trachomatis control requires a vaccine.Induction of immune memory by a multisubunit chlamydial vaccineTrachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis.Characterization of humoral immune responses to chlamydial HSP60, CPAF, and CT795 in inflammatory and severe trachoma.Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.All subtypes of the Pmp adhesin family are implicated in chlamydial virulence and show species-specific function.Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate.Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges.Altered developmental expression of polymorphic membrane proteins in penicillin-stressed Chlamydia trachomatis.The Chlamydial Type III Secretion Mechanism: Revealing Cracks in a Tough Nut.Systemic effector and regulatory immune responses to chlamydial antigens in trachomatous trichiasis.The role of Chlamydia trachomatis polymorphic membrane proteins in inflammation and sequelae among women with pelvic inflammatory diseaseIn vitro passage selects for Chlamydia muridarum with enhanced infectivity in cultured cells but attenuated pathogenicity in mouse upper genital tract.A re-evaluation of the role of B cells in protective immunity to Chlamydia infectionQuantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental formsConstruction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus.Bioinformatic Analysis of Chlamydia trachomatis Polymorphic Membrane Proteins PmpE, PmpF, PmpG and PmpH as Potential Vaccine Antigens.Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.Identification of antigen-specific antibody responses associated with upper genital tract pathology in mice infected with Chlamydia muridarum.Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies.Frequency of Chlamydia trachomatis-specific T cell interferon-γ and interleukin-17 responses in CD4-enriched peripheral blood mononuclear cells of sexually active adolescent females.Engineered phage-based therapeutic materials inhibit Chlamydia trachomatis intracellular infectionAnalysis of Humoral Immune Responses to Surface and Virulence-Associated Chlamydia abortus Proteins in Ovine and Human Abortions by Use of a Newly Developed Line ImmunoassayAnalysis of Polymorphic Membrane Protein Expression in Cultured Cells Identifies PmpA and PmpH of Chlamydia psittaci as Candidate Factors in Pathogenesis and Immunity to InfectionA Probiotic Adjuvant Lactobacillus rhamnosus Enhances Specific Immune Responses after Ocular Mucosal Immunization with Chlamydial Polymorphic Membrane Protein C.Unveiling New Molecular Factors Useful for Detection of Pelvic Inflammatory Disease due to Chlamydia trachomatis Infection.Directional evolution of Chlamydia trachomatis towards niche-specific adaptation.
P2860
Q28083729-A7B37633-DCC3-4C38-B80D-B2E18299B4ADQ28751868-D552D3A9-48C7-4E1B-AB2D-78A4A405D0E8Q30538838-C7719CBF-D188-4850-8666-84E181912587Q33288962-64437F32-A0DE-40F0-AB52-3A9225779FE7Q33298603-58F09BAC-E524-403D-8A59-A1C23D1F7D39Q33430259-FED19BCE-18AA-475D-A59E-FEFA671CF77DQ33584064-DE0C71D0-C260-4593-A6E3-15E83389B650Q33595583-3C4EA488-1F90-4AB4-9A67-03AE9FECA02EQ33721975-90268873-46D9-4F43-8230-8F2DDF0AA4E4Q33730339-281F2724-1D46-4753-94A1-51CB2BF967E6Q33751862-0638BBA3-B630-4C10-9F1C-E0C3124B958DQ33877047-BD4F40D1-ECDA-477A-9875-03CBA9C3A11BQ33899758-A8CDD1CB-7D92-45A4-B996-FF6ECEC44A58Q34103774-FDE73437-9C0D-4AF5-931F-4C514E2CCCC0Q34546923-49D20859-6420-4F37-8A00-6737344CD55AQ34607259-296D7B3C-DDC6-4F3E-B8DA-A9CAD2463824Q34735317-D46C02BF-C26C-4B4F-812B-07C393CF4675Q34739969-3D5EC6F5-4483-4B8E-B270-C94D2533BFA6Q34870145-3D6A468B-4EFC-47CB-A8C1-8DF692E243F7Q34883543-17A5EB13-D3F3-4A42-AF9C-421397C3A516Q35026625-9ADBADBA-82BF-438A-83A6-CA98C63812CFQ35050597-F2116803-4CCA-4CDF-8712-D93B653B4DBCQ35075114-D81CB516-B80F-496A-9CCC-3B5BE9B4D6C2Q35084474-4C8AA284-0661-4E85-A3AD-3446BF2E1DBCQ35417872-DD64DC15-925A-418F-9967-080C434831F3Q35439847-2648FFA1-F882-4451-918C-2F1E337CC19FQ35471373-A836F801-DC1C-4A6C-8F54-5EB2472EF123Q35577557-61C1E8CE-E0D2-4C9C-82AA-8DBB78DBF6BCQ35609703-7AB72D2D-796F-4CF4-BC27-FCF0E29E46E8Q35679647-CBA623CC-4EF9-4491-BA38-29B153620F3BQ35689196-E31D061B-0097-4443-BF40-CD4BD19FF80CQ35805521-99DA7519-F2EA-4C48-BEE5-DC7304379DAFQ35821088-19995AE0-BE31-4862-9A31-D0BDBAF0CC23Q35861640-9433CF26-83E2-4BF2-BCA1-F820A39B63FEQ35926041-E6068A33-FDB5-4CF8-A346-88396CB61055Q36021944-7D2F7E81-08C8-4CAF-8DB4-E1C3AFE65C3FQ36134315-87A61FB5-C5C1-4C59-A12D-82A25F1858ABQ36135698-4700CCEE-C7DE-4021-BF79-1A0D9AF9F11DQ36337305-73F4F44F-1CD7-4647-85D3-A34FE31618DFQ36363498-6A9EF62C-7E90-4415-ABB9-28A2023F6AB0
P2860
Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Chlamydia trachomatis polymorp ...... ommon pan-neutralizing antigen
@ast
Chlamydia trachomatis polymorp ...... ommon pan-neutralizing antigen
@en
Chlamydia trachomatis polymorp ...... ommon pan-neutralizing antigen
@nl
type
label
Chlamydia trachomatis polymorp ...... ommon pan-neutralizing antigen
@ast
Chlamydia trachomatis polymorp ...... ommon pan-neutralizing antigen
@en
Chlamydia trachomatis polymorp ...... ommon pan-neutralizing antigen
@nl
prefLabel
Chlamydia trachomatis polymorp ...... ommon pan-neutralizing antigen
@ast
Chlamydia trachomatis polymorp ...... ommon pan-neutralizing antigen
@en
Chlamydia trachomatis polymorp ...... ommon pan-neutralizing antigen
@nl
P2093
P2860
P356
P1476
Chlamydia trachomatis polymorp ...... ommon pan-neutralizing antigen
@en
P2093
Cho-chou Kuo
Deborah D Crane
Elizabeth R Fischer
Harlan D Caldwell
John H Carlson
Patrik Bavoil
Ru-ching Hsia
P2860
P304
P356
10.1073/PNAS.0508983103
P407
P577
2006-01-30T00:00:00Z